Perelman Center for Advanced Medicine

Philadelphia, Pennsylvania 19122

8 studies enrolling now · 54 studies all time

What they study most

Acute Myelogenous Leukemia, Adenocarcinoma, Alcohol Drinking, Alcohol Intoxication, Alopecia Areata, Atherosclerotic Cardiovascular Disease, Bladder Cancer, Breast Cancer, Cancer, Cancer of the Bladder, Recurrent, Carcinoid Tumor of the Small Bowel, Carcinoma

Studies at this site

• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention — Recruiting now
• A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Recruiting now
• Low Dose Radiotherapy for Osteoarthritis — Recruiting now
• Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES — Recruiting now
• Comparing Numbing Techniques in Mohs Micrographic Surgery — Recruiting now
• Kidney Transplant Improvement Through New Exercise Training to Increase Capacity — Recruiting now
• Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis — Completed
• SpaceIT Hydrogel System for Perirectal Spacing — Running, not enrolling
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial — Enrolling by invitation
• Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) — Completed
• Apremilast for Erythema Multiforme — Completed
• Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode — Running, not enrolling
• CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata — Completed
• Virtual Reality to Promote Relaxation Prior to Simulation — Completed
• BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy — Running, not enrolling
• Patient Ambassador — Completed
• Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light — Completed
• Advanced Heart Care at Home — Completed
• Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) — Completed
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment — Running, not enrolling
• TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis — Running, not enrolling
• First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221 — Completed
• Digital Incentive Spirometry Adherence — Completed
• Project Looking-Glass Evaluation — Running, not enrolling
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) — Completed
• Evaluating Perceived Fitness to Drive While Intoxicated — Completed
• Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders — Stopped early
• Ultrasound Efficacy in Moderate Rheumatoid Arthritis — Completed
• COVID-19 Watch + COVID-19 Pulse — Completed
• GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
• Improving Physical Activity and Cardiac Rehabilitation Attendance Using Technology and Behavioral Economics — Withdrawn before enrolling
• Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) — Completed
• A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma — Stopped early
• TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early
• Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver Transplantation — Completed
• A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours — Completed
• Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients — Stopped early
• Evaluation of the Novel Use of Gamification With Alternative Goal-setting Experiences — Completed
• Buddy Relationships in DermatoloGic Excisions for Skin Cancer — Completed
• Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers — Completed
• A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis — Completed
• Kinetic Anesthesia Device Study — Completed
• Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial Incentives — Completed
• Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes — Completed